To prevent neutropenia-related infections, cancer patients are usually administered a hematopoietic growth factor-granulocyte colony-stimulating factor (G-CSF), which stimulates the de novo generation of neutrophils through bone marrow (BM) hematopoiesis2. This evidence concerns the gene CSF3 and cancer.